确定PDE4作为urolithin-A的新目标,以缓解视网膜色素表皮细胞中LPS诱导的炎症

Likhitha Purna Kondapaneni1,2,3, Meenakshi Arora1,2,3,4, Erin M Scott5

  • 1The Center for Convergent Bioscience and Medicine (CCBM), The University of Alabama, Tuscaloosa, AL, USA.

Pharmaceutical research
|September 22, 2025
PubMed
概括

乌罗立A (UA) 显示出作为一种新型抗炎剂的潜力,通过抑制二酶4 (PDE4) 来治疗眼部疾病. 这种肠道代谢物有效地减少了眼细胞的炎症,为现有治疗方法提供了更安全的替代方案.